Prelude Capital Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Prelude Capital Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,615	Closed	-$201K	–	1145
2025 Q1	$201K	Buy	+1,615	New	+$201K	0.02%	859
2022 Q4	–	Sell	-3,277	Closed	-$437K	–	1322
2022 Q3	$437K	Buy	+3,277	New	+$437K	0.02%	688
2021 Q1	–	Sell	-4,074	Closed	-$672K	–	1245
2020 Q4	$672K	Buy	+4,074	New	+$672K	0.02%	291
2020 Q1	–	Sell	-654	Closed	-$98K	–	1243
2019 Q4	$98K	Buy	+654	New	+$98K	﹤0.01%	745
2019 Q3	–	Sell	-2,230	Closed	-$318K	–	1382
2019 Q2	$318K	Buy	2,230 +2,171	+3,680%	+$310K	0.02%	356
2019 Q1	$8K	Sell	59 -1,168	-95%	-$158K	﹤0.01%	1142
2018 Q4	$152K	Sell	1,227 -13,848	-92%	-$1.72M	0.01%	579
2018 Q3	$2.54M	Sell	15,075 -12,318	-45%	-$2.07M	0.15%	93
2018 Q2	$4.72M	Buy	27,393 +282	+1%	+$48.6K	0.3%	43
2018 Q1	$4.09M	Sell	27,111 -255	-0.9%	-$38.5K	0.3%	49
2017 Q4	$3.69M	Sell	27,366 -2,946	-10%	-$397K	0.3%	54
2017 Q3	$4.43M	Buy	30,312 +13,553	+81%	+$1.98M	0.4%	43
2017 Q2	$2.61M	Buy	16,759 +645	+4%	+$100K	0.25%	80
2017 Q1	$2.34M	Sell	16,114 -1,475	-8%	-$214K	0.22%	96
2016 Q4	$1.92M	Buy	17,589 +6,824	+63%	+$744K	0.23%	113
2016 Q3	$1.31M	Buy	10,765 +7,690	+250%	+$934K	0.14%	157
2016 Q2	$435K	Buy	3,075 +955	+45%	+$135K	0.06%	276
2016 Q1	$277K	Buy	2,120 +380	+22%	+$49.7K	0.04%	380
2015 Q4	$245K	Sell	1,740 -275	-14%	-$38.7K	0.04%	426
2015 Q3	$268K	Sell	2,015 -140	-6%	-$18.6K	0.04%	423
2015 Q2	$379K	Sell	2,155 -1,020	-32%	-$179K	0.05%	349
2015 Q1	$549K	Buy	3,175 +1,475	+87%	+$255K	0.08%	296
2014 Q4	$278K	Buy	1,700 +200	+13%	+$32.7K	0.04%	491
2014 Q3	$241K	Sell	1,500 -200	-12%	-$32.1K	0.03%	579
2014 Q2	$250K	Hold	1,700	–	–	0.03%	571
2014 Q1	$236K	Sell	1,700 -1,600	-48%	-$222K	0.03%	588
2013 Q4	$418K	Buy	3,300 +300	+10%	+$38K	0.07%	363
2013 Q3	$276K	Buy	3,000 +1,500	+100%	+$138K	0.04%	384
2013 Q2	$103K	Buy	+1,500	New	+$103K	0.02%	554